By contrast, expression of p-GSK3β-Ser9 relative to GSK3β exhibited a decrease in 3×Tg-AD mice (p = 0.0834), but it significantly increased after CY-09 treatment, with a p-value lower than 0.05. This evidence concerns the gene GSK3B and Alzheimer disease.